Answers are grounded in this paper and cite their sources.
Case report reveals olanzapine leads to hyperpigmentation in a schizophrenia patient, highlighting adverse effects.
Olanzapine is an atypical antipsychotic used for the treatment of Schizophrenia. Its common adverse effects include weight gain, sedation, and metabolic disturbances, but dermatological side effects are relatively rare. This case report discusses the case of a patient with Schizophrenia who developed progressive hyperpigmentation following olanzapine use. As there was a temporal association, drug-induced hyperpigmentation was considered. Other potential causes of hyperpigmentation were ruled out, and the hyperpigmentation resolved 1 month after discontinuation of olanzapine. This case highlights the need for clinicians to be aware of the rare dermatological side effects of antipsychotics, ensuring timely recognition and management.
No takes yet. Share an insight, caveat, or question.
Kelkar et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: